Uni-Bio Science Group Ltd
00690
Company Profile
Business description
Uni-Bio Science Group Ltd is an investment holding company. It operates in three segments: Chemical pharmaceutical products, Biological pharmaceutical products, and Pipeline products. Its geographical segments are Hong Kong and China, of which all of its revenue comes from China. The company products include GeneSoft, GeneTime, Pinup, Boshutai, Bokangtai, and others. All of the company revenue is generated from PRC.
Contact
No. 20 Science Park East Avenue
Unit 502, 5th Floor, Hong Kong Science Park
Shatin, New Territories
Hong Kong
HKGT: +852 31023232
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
504
Stocks News & Analysis
stocks
Chart of the Week: Inflation fears dampen sentiment on retailers
Rising inflation is the fly in the ointment.
stocks
Here’s 3 Top Rated ASX shares for 2026
As we start the new year, let’s take a closer look at three compelling opportunities on the ASX
stocks
Undervalued Aussie e-commerce winner
Shares attractive due to near term profit margin increase and structural growth.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,046.50 | 7.00 | 0.08% |
| CAC 40 | 8,243.47 | 6.04 | 0.07% |
| DAX 40 | 25,080.10 | 42.16 | -0.17% |
| Dow JONES (US) | 49,263.58 | 267.50 | 0.55% |
| FTSE 100 | 10,021.34 | 26.87 | -0.27% |
| HKSE | 26,149.31 | 561.14 | -2.10% |
| NASDAQ | 23,454.05 | 93.12 | -0.40% |
| Nikkei 225 | 51,117.26 | 1,400.82 | -2.67% |
| NZX 50 Index | 13,716.86 | 1.84 | 0.01% |
| S&P 500 | 6,918.46 | 2.47 | -0.04% |
| S&P/ASX 200 | 8,720.80 | 2.70 | -0.03% |
| SSE Composite Index | 4,082.98 | 2.79 | -0.07% |